President Trump has signed an executive order to ease research restrictions on psychedelics, including the drug ibogaine, which is used in some countries to treat post-traumatic stress disorder. Health officials, including Health and Human Services Secretary Robert F. Kennedy Jr., and podcaster Joe Rogan joined Mr. Trump in the Oval Office for the signing Saturday.
REMOVING BARRIERS TO PSYCHEDELIC DRUGS AS POTENTIAL TREATMENT FOR SERIOUS MENTAL ILLNESS: Today, President Donald J. Trump signed an Executive Order that will accelerate access to treatments for patients with serious mental illness, reaffirming his commitment to advancing solutions that provide hope to Americans with devastating, complex, and treatment-resistant conditions. The Order directs the Food
The White House April 18, 2026 On Saturday, April 18, 2026, the President signed into law: H.R. 8322, which extends the authorities in title VII of the Foreign Intelligence Surveillance Act relating to foreign intelligence gathering. Original Story Link
Construction is underway on a ballroom being added to the East Wing of the White House in Washington, on Nov. 17, 2025. Madalina Kilroy /The Epoch Times A U.S. appeals court on April 17 put on hold a lower court order that had halted construction of the White House ballroom, allowing the project to proceed
By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1. Purpose and Policy. Policymakers and the medical field have long struggled to address the burden of suicide and serious mental illness rates in America. Today, over 14 million American
The Internal Revenue Service in Washington on Jan. 6, 2026. Madalina Kilroy/The Epoch Times Settlement talks are underway between President Donald Trump and the IRS over a $10 billion lawsuit Trump filed against the tax collection agency, according to a federal court filing submitted on April 17 in Miami. Trump’s lawyers asked a U.S. district
President Trump has signed an executive order to ease restrictions on the psychedelic ibogaine, signaling the administration’s willingness to further U.S. research into the drug, which is used in some countries to treat post-traumatic stress disorder. Mr. Trump was joined by health officials including Health and Human Services Secretary Robert F. Kennedy Jr. and podcaster